1min snip

The Jason Wright Show cover image

Semaglutide, Ozempic, Terzepetide Weight Loss MasterClass With Dr. Gus Vickery, M.D.

The Jason Wright Show

NOTE

The Potential of Semaglutide and Tirzepatide as Peptides for Diabetes and Obesity

To zepatide, a phenomenal but expensive peptide, is a dual GLP1 and GIP agonist with a powerful impact on appetite and less intense side effects compared to semaglutide. It is expected to gain popularity when it receives its obesity indication.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode